Improved fertility following ectopic pregnancy

Sherman, Dan; Langer, R.; Sadovsky, G.; Bukovsky, Ian; Caspi, Eliahu

doi:10.1016/s0015-0282(16)46155-8

Cited by 81 publications

(14 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Specific conditions for which ART may be indicated include (1) alternative to neosalpingostomy, (2) alternative for patients with postinfectious tubal disease, (3) alternative to repeat tuboplasty, (4) alternative to tubal implantation for some patients, and (5) patients who wish to avoid a major surgical procedure. Journal of Gynecologic Surgery Fulguration of endometrial implants Radical endometriosis surgery (plus danazol) Recurrent endometriosis (conservative surgery) [40][41][42][43][44][45][46][47] Salpingostomy (for ectopic pregnancy) Salpingostomy (tubal reconstruction) [21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39] Salpingostomy (postinfectious) [14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29] Neosalpingostomy Fimbrioplasty …”

Section: Resultsmentioning

confidence: 99%

“…Tubal anastomosis (postinfectious) 43 Tubal anastomosis (uterotubal junction obstruction) [50][51][52][53][54][55][56][57][58][59][60][61][62][63][64][65][66][67][68][69] Tubal implantation (Reamer or cornual excision) Tubal implantation (posterior wall) Repeat tuboplasties [6][7][8][9][10][11][12][13][14][15][16][17][18][19][20] This is true if one only considers pregnancy rates when counseling patients. Invariably, numerous other factors must also be considered.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Reproductive Surgery vs Assisted Reproductive Technologies: Selecting the Correct Alternative

Silverberg

Hill

1991

Journal of Gynecologic Surgery

View full text Add to dashboard Cite

Many innovations have been made in advanced reproductive technologies (ART) over the past several years. These procedures now yield pregnancy rates of over 20% per cycle, rates that compare favorably to many types of reproductive surgery. Therefore, ART now represents a viable alternative for many patients suffering from infertility. As these pregnancy rates continue to rise, gynecologists will have to choose between ART and reproductive surgery for a larger number of patients. This article reviews the commonly performed reproductive surgical procedures and compares expected postoperative pregnancy rates to those of ART in order to help the gynecologist make this decision.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Reproductive Surgery vs Assisted Reproductive Technologies: Selecting the Correct Alternative

Silverberg

Hill

1991

Journal of Gynecologic Surgery

View full text Add to dashboard Cite

show abstract

“…[17] The main reasons that can explain the decreased fertility rate after treatment of EP include age higher than 35 years, tubal abnormality, low socioeconomic state, adnexal adhesion, history of ruptured EP, and type of treatment(medication v/s surgery). [18,19] In a prospective randomized clinical trial, Fernandez et al compared the efficacy of MTX treatment with salpingectomy on subsequent fertility in the women with EP and concluded that MTX is as efficient as laparoscopic salpingectomy surgery in improving subsequent fertility. [20] However, in other study conducted by Fernandez et al, no significant difference in subsequent fertility was reported between MTX and surgical treatments.…”

Section: Original Articlementioning

confidence: 99%

Untitled

Askari¹

2018

AJP

View full text Add to dashboard Cite

Background and Objective: Ectopic pregnancy (EP) is a serious cause of maternal mortality that complicates about 2% of pregnancies. There are two approaches for EP treatments including surgical intervention and methotrexate (MTX). The present study aims to comparatively investigate impacts of single-dose MTX and laparoscopic salpingectomy treatments on ovarian reserve in women with EP using anti-Mullerian hormone (AMH) level as the biomarker of subsequent pregnancy. Materials and Methods: This was a prospective randomized clinical trial conducted on 30 patients with EP who referred to two University Hospitals in Shiraz during December 2014-June 2016. The subjects were divided into single-dose MTX group and salpingectomy group. Before the treatments and at 6-month posttreatment follow-up, the serum AMH level was measured using ELIZA method and compared within and between groups. Results: The serum AMH level significantly decreased in both groups at 6-month post-treatment compared with the baseline levels (P = 0.05). The single-dose MTX group showed more reduction than the surgery group (1.6 vs. 1.2 pg/mL). However, the difference in the post-treatment serum AMH level was not statistically significant between the two groups (P > 0.05). Conclusion: Both single-dose MTX group and salpingectomy treatments are effective for EP. For patients with less severe EP, it is recommended to administer single-dose MTX than surgical approach.

show abstract

“…Dans cette étude, le taux de récidive de GEU est de 27 %, similaire après traitement initial radical ou conservateur. La technique chirurgicale, comme facteur de risque de récidive de GEU, est encore sujette à discussion puisque certaines séries [13][14][15][16] ne retrouvent aucune différence significative, alors que d'autres études [17][18][19][20] retrouvent un taux de récidive plus important après traitement conservateur.…”

Section: Salpingotomie Versus Salpingectomie Par Voie Coelioscopiqueunclassified